Box 12
Contains 14 Results:
Antihypertensive Research--"Method for the Evaluation of Antihypertensive Agents" Paper, 1960
Subseries 9A addresses well over one hundred subjects, with emphasis placed on barbiturate, cinchona alkaloid and diuretics studies, heart conditions and heart disease, and the development of experimental drugs. The files within this subseries consist of Gold’s handwritten and typed notes, as well as journal articles, newspaper clippings, brochures and advertisements for new medications, and academic papers.
Antihypertensive Research--Mebutamate (W583) First Assay (RESTRICTED-PHI), 1961
Subseries 9A addresses well over one hundred subjects, with emphasis placed on barbiturate, cinchona alkaloid and diuretics studies, heart conditions and heart disease, and the development of experimental drugs. The files within this subseries consist of Gold’s handwritten and typed notes, as well as journal articles, newspaper clippings, brochures and advertisements for new medications, and academic papers.
Digitoxin Research and Clinical Studies, 1926-1965
Subseries 8C comprises Gold’s comparisons of specific digitalis compounds such as digifolein, digilanide, and digitoxin. Correspondence, research notes and bio-assay results highlight Gold’s extensive studies. Manuscripts and papers documenting his lab work are also included.
Digoxin Protocols--Patient Charts (Folder 2 of 2) (RESTRICTED-PHI), 1946
Subseries 8C comprises Gold’s comparisons of specific digitalis compounds such as digifolein, digilanide, and digitoxin. Correspondence, research notes and bio-assay results highlight Gold’s extensive studies. Manuscripts and papers documenting his lab work are also included.
Digitoxin/Digitaline Nativelle Notes and Reprints, 1940-1945
Subseries 8C comprises Gold’s comparisons of specific digitalis compounds such as digifolein, digilanide, and digitoxin. Correspondence, research notes and bio-assay results highlight Gold’s extensive studies. Manuscripts and papers documenting his lab work are also included.
Antihistaminic Drugs, 1946
Subseries 9A addresses well over one hundred subjects, with emphasis placed on barbiturate, cinchona alkaloid and diuretics studies, heart conditions and heart disease, and the development of experimental drugs. The files within this subseries consist of Gold’s handwritten and typed notes, as well as journal articles, newspaper clippings, brochures and advertisements for new medications, and academic papers.
Antihypertensive Research, 1951-1964
Subseries 9A addresses well over one hundred subjects, with emphasis placed on barbiturate, cinchona alkaloid and diuretics studies, heart conditions and heart disease, and the development of experimental drugs. The files within this subseries consist of Gold’s handwritten and typed notes, as well as journal articles, newspaper clippings, brochures and advertisements for new medications, and academic papers.
Anti-Coagulants, 1942-1960
Subseries 9A addresses well over one hundred subjects, with emphasis placed on barbiturate, cinchona alkaloid and diuretics studies, heart conditions and heart disease, and the development of experimental drugs. The files within this subseries consist of Gold’s handwritten and typed notes, as well as journal articles, newspaper clippings, brochures and advertisements for new medications, and academic papers.
Ditoxin Study (RESTRICTED-PHI), 1948-1950
Subseries 8C comprises Gold’s comparisons of specific digitalis compounds such as digifolein, digilanide, and digitoxin. Correspondence, research notes and bio-assay results highlight Gold’s extensive studies. Manuscripts and papers documenting his lab work are also included.
Antihypertensive Research--Mebutamate (W583) Study, 1960-1964
Subseries 9A addresses well over one hundred subjects, with emphasis placed on barbiturate, cinchona alkaloid and diuretics studies, heart conditions and heart disease, and the development of experimental drugs. The files within this subseries consist of Gold’s handwritten and typed notes, as well as journal articles, newspaper clippings, brochures and advertisements for new medications, and academic papers.